Keith E. Donovan

4/3/2026 6:25:08 PM

Morris James Investigating Olympus Scope Infection Claims

By Keith E. Donovan Matthew R. Fogg

Morris James LLP is now accepting cases on behalf of patients who developed serious infections after an endoscopy, gastroscopy,...

4/1/2026 2:27:37 PM

By Keith E. Donovan Matthew R. Fogg

Dupixent (dupilumab) has been a genuine breakthrough for many families. For children with moderate-to-severe eczema, asthma, and other...

3/24/2026 8:08:38 PM

By Keith E. Donovan Matthew R. Fogg Ashley C. Curran

Morris James is investigating claims that Ozempic, Wegovy, and other GLP-1 medications have been linked to serious, permanent vision...

3/20/2026 8:33:37 PM

By Keith E. Donovan Matthew R. Fogg

Morris James LLP is now accepting cases on behalf of patients who suffered serious vision loss after taking GLP-1 medications such as...

3/20/2026 6:43:07 PM

By Matthew R. Fogg Keith E. Donovan

By: Keith Donovan and Matthew Fogg Key Takeaways The FDA has identified a Class I recall (its most serious type) involving certain...

3/19/2026 5:06:37 PM

By Keith E. Donovan Matthew R. Fogg

By: Keith Donovan and Matthew Fogg The FDA has expanded approval of Dupixent® (dupilumab) for children aged six and older with allergic...

2/26/2026 9:23:07 PM

By Matthew R. Fogg Keith E. Donovan

For many people living with severe eczema, Dupixent feels like a breakthrough. After years of painful flare-ups, constant itching, and...

2/13/2026 12:59:37 PM

By Keith E. Donovan Matthew R. Fogg

If you or someone you love uses Dupixent, you may have recently seen television ads or online headlines linking the medication to rare...